Sichuan Hebang Biotechnology Corporation Statistics
Total Valuation
Sichuan Hebang Biotechnology Corporation has a market cap or net worth of CNY 17.09 billion. The enterprise value is 18.58 billion.
Market Cap | 17.09B |
Enterprise Value | 18.58B |
Important Dates
The last earnings date was Monday, October 21, 2024.
Earnings Date | Oct 21, 2024 |
Ex-Dividend Date | Oct 15, 2024 |
Share Statistics
Sichuan Hebang Biotechnology Corporation has 8.03 billion shares outstanding. The number of shares has decreased by -4.23% in one year.
Current Share Class | n/a |
Shares Outstanding | 8.03B |
Shares Change (YoY) | -4.23% |
Shares Change (QoQ) | -2.91% |
Owned by Insiders (%) | 5.96% |
Owned by Institutions (%) | 4.92% |
Float | 4.68B |
Valuation Ratios
The trailing PE ratio is 36.66.
PE Ratio | 36.66 |
Forward PE | n/a |
PS Ratio | 1.93 |
PB Ratio | 0.91 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.45, with an EV/FCF ratio of -19.93.
EV / Earnings | 38.28 |
EV / Sales | 2.02 |
EV / EBITDA | 11.45 |
EV / EBIT | 32.87 |
EV / FCF | -19.93 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.18.
Current Ratio | 1.88 |
Quick Ratio | 0.95 |
Debt / Equity | 0.18 |
Debt / EBITDA | 2.12 |
Debt / FCF | -3.69 |
Interest Coverage | 13.23 |
Financial Efficiency
Return on equity (ROE) is 2.31% and return on invested capital (ROIC) is 1.56%.
Return on Equity (ROE) | 2.31% |
Return on Assets (ROA) | 1.39% |
Return on Capital (ROIC) | 1.56% |
Revenue Per Employee | 1.28M |
Profits Per Employee | 67,725 |
Employee Count | 7,169 |
Asset Turnover | 0.36 |
Inventory Turnover | 1.80 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.17% in the last 52 weeks. The beta is 0.32, so Sichuan Hebang Biotechnology Corporation's price volatility has been lower than the market average.
Beta (5Y) | 0.32 |
52-Week Price Change | -7.17% |
50-Day Moving Average | 1.91 |
200-Day Moving Average | 2.02 |
Relative Strength Index (RSI) | 58.97 |
Average Volume (20 Days) | 162,991,949 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sichuan Hebang Biotechnology Corporation had revenue of CNY 9.20 billion and earned 485.52 million in profits. Earnings per share was 0.06.
Revenue | 9.20B |
Gross Profit | 1.18B |
Operating Income | 565.37M |
Pretax Income | 585.63M |
Net Income | 485.52M |
EBITDA | 1.61B |
EBIT | 565.37M |
Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 2.57 billion in cash and 3.44 billion in debt, giving a net cash position of -873.33 million or -0.11 per share.
Cash & Cash Equivalents | 2.57B |
Total Debt | 3.44B |
Net Cash | -873.33M |
Net Cash Per Share | -0.11 |
Equity (Book Value) | 19.38B |
Book Value Per Share | 2.34 |
Working Capital | 5.07B |
Cash Flow
In the last 12 months, operating cash flow was -204.59 million and capital expenditures -728.02 million, giving a free cash flow of -932.60 million.
Operating Cash Flow | -204.59M |
Capital Expenditures | -728.02M |
Free Cash Flow | -932.60M |
FCF Per Share | -0.12 |
Margins
Gross margin is 12.84%, with operating and profit margins of 6.14% and 5.28%.
Gross Margin | 12.84% |
Operating Margin | 6.14% |
Pretax Margin | 6.36% |
Profit Margin | 5.28% |
EBITDA Margin | 17.48% |
EBIT Margin | 6.14% |
FCF Margin | -10.13% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.87%.
Dividend Per Share | 0.04 |
Dividend Yield | 1.87% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | 17.19% |
Buyback Yield | 4.23% |
Shareholder Yield | 6.10% |
Earnings Yield | 2.73% |
FCF Yield | -5.46% |
Stock Splits
The last stock split was on July 5, 2017. It was a forward split with a ratio of 2.2.
Last Split Date | Jul 5, 2017 |
Split Type | Forward |
Split Ratio | 2.2 |
Scores
Sichuan Hebang Biotechnology Corporation has an Altman Z-Score of 2.85. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.85 |
Piotroski F-Score | n/a |